PATH | VRL
Menu
We've moved! Same resources, new address: vaccineresources.org

Find resources

Total results with these characteristics: 1196

Topic: Disease/vaccine specific information

Page 59 of 60
Vaccines for the Future

Published from 2007 to 2015, this quarterly e-newsletter provided updates on PATH’s efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world …

Author: PATH

Vaccines for the Unvaccinated: Protecting the Herd

This editorial, published in The Journal of Infectious Diseases, provides commentary on the effect of vaccines in protecting the unvaccinated through herd immunity and using this effect as an important consideration in strategies for vaccine …

Author: Stephens DS

Publication date: 2008

Vaccines in the Era of Genomics: The Pneumococcal Challenge

Published in the journal Vaccine, this review aims to provide the reader with an understanding of the capsular-based complexity of Streptococcus pneumoniae, one of the main limitations to current vaccine development; the need for a new vaccine …

Author: Barocchi MA, Censini S, Rappuoli R

Publication date: 2007

Vaccines.gov

This website is a gateway to information from the United States government on vaccines and immunization for infants, children, teenagers, adults, and seniors. It provides resources from US federal agencies for the general public and their …

Author: US Department of Health and Human Services

The Value of Demonstration Projects for New Interventions: The Case of Human Papillomavirus Vaccine Introduction in Low and Middle-Income Countries

This article, published in Human Vaccines & Immunotherapeutics, examines the value of human papillomavirus (HPV) vaccination demonstration projects, including potential drawbacks and how value for informing national scale-up might be increased. …

Author: Howard N, Mounier-Jack S, Gallagher KE, et al.

Publication date: 2016

The Value of Investing in Vaccines

This infographic illustrates the economic benefits of immunization. It is specifically focused on how delivering three childhood vaccines—Haemophilus influenzae type b, pneumococcal, and rotavirus—in the world's 73 poorest countries could result …

Author: International Vaccine Access Center

Publication date: 2012

Variation in Rotavirus Vaccine Coverage by Provider Location and Subsequent Disease Burden

This article, published in Pediatrics, reports on a study that examined variation in rotavirus vaccine coverage among provider locations in the United States and correlated coverage with the detection of rotavirus in children who sought treatment of …

Author: Sahni LC, Tate JE, Payne DC, Parashar UD, Boom JA

Publication date: 2015

Vial Usage, Device Dead Space, Vaccine Wastage, and Dose Accuracy of Intradermal Delivery Devices for Inactivated Poliovirus Vaccine (IPV)

This article, published in Vaccine, reports the results of a study to assess different intradermal delivery devices for inactivated polio vaccine. Results showed wide variability between the devices in dead space, dose accuracy, overall wastage, and …

Author: Jarrahian C, Rein-Weston A, Saxon G, et al.

Publication date: 2017

VIEW-hub

This online database provides real-time data on vaccine introductions and impact. The Vaccine Information and Epidemiology Window (VIEW-hub) includes information related to rotavirus, pneumococcal, Haemophilus influenzae type b, and inactivated …

Author: International Vaccine Access Center

VIEW-hub – Vaccine Information and Epidemiology Window

This web page provides a link to the most recent VIEW-hub Report, as well as an archive of earlier reports. This quarterly report provides data and figures on the introduction status of Haemophilus influenzae type b, pneumococcal conjugate, …

Author: International Vaccine Access Center

Vigilancia Epidemiológica de Diarreas Causadas por Rotavirus

This Spanish-language document provides information on rotavirus disease and vaccines, including epidemiology and prevention and treatment of the disease.

Author: Pan American Health Organization

Publication date: 2007

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

The authors of this article, published in the Journal of Virology, discuss the contributions of viral versus various host factors to respiratory syncytial virus (RSV) pathogenesis. The authors conclude that a better understanding of the viral and …

Author: Collins PL, Graham BS

Publication date: 2008

What Do the Next 100 Years Hold for Pneumococcal Vaccination?

This editorial article, published in Expert Review of Vaccines, provides a brief historical overview of vaccination against pneumococcal disease and offers a perspective on the future of pneumococcal vaccines. The authors describe the …

Author: Rijkers GT, van Mens SP, van Velzen-Blad H

Publication date: 2010

What Would Happen if We Stopped Vaccinations?

This web page provides a summary of disease-related consequences of stopping immunizations. Vaccination programs have eliminated or significantly reduced many vaccine-preventable diseases in the United States and elsewhere. However, these diseases …

Author: US Centers for Disease Control and Prevention

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

Published in the journal Clinical Infectious Diseases, this study analyzed more than 70 recent data sets to compare the serogroups causing invasive pneumococcal disease with those represented in conjugate vaccine formulations. ABSTRACT ONLY. (Learn …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

White Paper – Rotavirus: Common, Severe, Devastating, Preventable

This white paper provides a comprehensive source of information on rotavirus disease and vaccines. The 50-page synthesis includes the latest evidence and programmatic information about: rotavirus disease burden; vaccines in global use, nationally …

Author: ROTA Council

Publication date: 2016

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool User Guide

The World Health Organization has developed a generic costing and planning tool for cervical cancer prevention and control to help program planners and managers generate annual cost projections over a five-year period to scale-up human …

Author: World Health Organization

Publication date: 2012

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

Page 59 of 60